Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR3107)
Received: 14 October 2020
Accepted: 2 April 2021
First Online: 3 May 2021
: This study was conducted under a human research protocol #204503 approved by the Institutional Review Board (IRB) of the University of Arkansas for Medical Sciences (UAMS, Little Rock, AR). All participants voluntarily provided written informed consent. All the cell lines used in the study was approved by our institutional biosafety protocol (BP#161).
: Not applicable.
: The authors have no competing interests.